Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman PR Newswire OXFORD, England, June 26, 2013 OXFORD, England, June 26, 2013...
With 2011 coming to an end, the pharmaceutical industry continues to face challenges like sluggish prescription trends, EU pricing pressure...
• Blackstone Group (NYSE:BX) posted a Q3 loss of $0.31 per share, lower than the Zacks Consensus Estimate of $0.05 per...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has completed its acquisition of Cephalon, Inc...
The European Commission's Antitrust unit cleared Friday the acquisition of US-based pharmaceutical company Cephalon Inc. (CEPH) by the generic...
Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the...
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon Inc. (NASDAQ: CEPH) announced today that they received approval...
S&P Indices Announces Change to U.S. Index PR Newswire NEW YORK, Oct. 11, 2011 NEW YORK, Oct. 11, 2011 /PRNewswire/ -- TE Connectivity Ltd...
Teva Pharmaceutical Industries Ltd. (TEVA) is a step closer to acquiring Cephalon, Inc. (CEPH) with the US Federal Trade Commission (FTC...
The Hart-Scott-Rodino Act requires under certain circumstances that prospective acquirers of voting securities or assets apply for clearance from...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover...
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced its plans to acquire the remaining 50% interest of its Japanese joint venture...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.